BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 36242682)

  • 1. Cervical cancer in Ethiopia: a review of the literature.
    Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
    Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus genotype distribution in Ethiopia: an updated systematic review.
    Derbie A; Mekonnen D; Nibret E; Maier M; Woldeamanuel Y; Abebe T
    Virol J; 2022 Jan; 19(1):13. PubMed ID: 35033141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
    Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
    Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
    PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of high- and low-risk human papillomavirus genotypes and their prophylactic vaccination coverage among West African women: systematic review.
    Ouedraogo RA; Kande A; Nadembega WMC; Ouermi D; Zohoncon TM; Djigma FW; Ouedraogo CMR; Lompo OM; Simpore J
    J Egypt Natl Canc Inst; 2023 Dec; 35(1):39. PubMed ID: 38060078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
    Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
    Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
    Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
    BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public School Adolescents Had Increased Odds of Being Willing to Uptake HPV Vaccinations Owing to Sociodemographic and Healthcare Access Features in Bahir Dar City, Ethiopia.
    Shitu BF; Atnafu DD; Agumas Y
    Biomed Res Int; 2023; 2023():2663815. PubMed ID: 37090189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis.
    Zewdie A; Kasahun AW; Habtie A; Gashaw A; Ayele M
    BMC Public Health; 2023 Jul; 23(1):1369. PubMed ID: 37461006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Variation of Human Papillomavirus Genotypes and Selected Genes Involved in Cervical Malignancies.
    Husain RS; Ramakrishnan V
    Ann Glob Health; 2015; 81(5):675-83. PubMed ID: 27036725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women.
    Abate A; Munshea A; Nibret E; Alemayehu DH; Alemu A; Abdissa A; Mihret A; Abebe M; Mulu A
    Sci Rep; 2024 Apr; 14(1):7976. PubMed ID: 38575600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitude, and uptake of human papillomavirus vaccine among adolescent schoolgirls in Ethiopia: a systematic review and meta-analysis.
    Addisu D; Gebeyehu NA; Belachew YY
    BMC Womens Health; 2023 May; 23(1):279. PubMed ID: 37210492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.
    Tesfaye E; Kumbi B; Mandefro B; Hemba Y; Prajapati KK; Singh SC; Upadhye V; Hajare ST
    Sci Rep; 2024 Feb; 14(1):4053. PubMed ID: 38374354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
    Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
    Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
    Ruan Y; Li H; Liu M; Cao G; Xu X; Han L; Li F
    Cancer Epidemiol; 2023 Jun; 84():102372. PubMed ID: 37119603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.